+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 102791-87-7
102791-87-7,MFCD09834629
Catalog No.:AA007YGD

102791-87-7 | 4-(4-Methyl-1h-imidazol-1-yl)benzenamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
≥ 98% (HPLC)
in stock  
$202.00   $141.00
- +
100mg
95%
in stock  
$304.00   $213.00
- +
250mg
≥ 98% (HPLC)
in stock  
$659.00   $461.00
- +
1g
≥ 98% (HPLC)
in stock  
$1,346.00   $942.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA007YGD
Chemical Name:
4-(4-Methyl-1h-imidazol-1-yl)benzenamine
CAS Number:
102791-87-7
Molecular Formula:
C10H11N3
Molecular Weight:
173.2144
MDL Number:
MFCD09834629
SMILES:
Nc1ccc(cc1)n1cnc(c1)C
Properties
Computed Properties
 
Complexity:
164  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
1.4  

Downstream Synthesis Route
102791-87-7    936092-53-4   
N-tert-butyl-3-{5-methyl-2-4-(4-methyl-imidazol-1-yl)-phenylamino-pyrimidin-4-ylamino}-benzenesulfonamide 

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2007/53452,2007,A1Locationinpatent:Page/Pagecolumn170-171

102791-87-7    936092-60-3   
N4-(3-tert-butylphenyl)-5-methyl-N2-(4-(4-methyl-1H-imidazol-1-yl)phenyl)pyrimidine-2,4-diaminehydrochloride 

[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2007/53452,2007,A1Locationinpatent:Page/Pagecolumn188

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2012/208798,2012,A1Locationinpatent:Page/Pagecolumn44

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/54848,2011,A1Locationinpatent:Page/Pagecolumn75

[3]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/54841,2011,A1Locationinpatent:Page/Pagecolumn98

[4]CurrentPatentAssignee:FORUMPHARMACEUTICALSINC-WO2015/66697,2015,A1Locationinpatent:Paragraph0303

[5]CurrentPatentAssignee:DENALITHERAPEUTICSINC-WO2015/109109,2015,A1Locationinpatent:Paragraph0302

[6]CurrentPatentAssignee:DENALITHERAPEUTICSINC-US2017/44182,2017,A1Locationinpatent:Paragraph0319

[7]CurrentPatentAssignee:ROTTAPHARMBIOTECHS.R.L.-WO2009/152868,2009,A1Locationinpatent:Page/Pagecolumn49-50

[8]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2007/53452,2007,A1Locationinpatent:Page/Pagecolumn188

[9]CurrentPatentAssignee:WHITEHEADINSTITUTEFORBIOMEDICALRESEARCH;DANA-FARBERCANCERINSTITUTE-WO2010/44885,2010,A2Locationinpatent:Page/Pagecolumn93-94

[10]CurrentPatentAssignee:ROCHEHOLDINGAG-US2008/280948,2008,A1Locationinpatent:Page/Pagecolumn24

[1]CurrentPatentAssignee:HORIZONPHARMAPUBLICLIMITEDCOMPANY-WO2008/137102,2008,A2Locationinpatent:Page/Pagecolumn59

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 102791-87-7
88091-36-5

88091-36-5

 127404-21-1

127404-21-1

 884199-52-4

884199-52-4

 1429649-60-4

1429649-60-4

 136167-38-9

136167-38-9

 252340-70-8

252340-70-8
Building Blocks
More >
Tags:102791-87-7 Molecular Formula|102791-87-7 MDL|102791-87-7 SMILES|102791-87-7 4-(4-Methyl-1h-imidazol-1-yl)benzenamine